Ashish K. Jha, MD, MPH, discusses how the World Health Organization and other public health agencies are handling the Zika virus, and what role the media plays in their responses to global pandemics.
Ashish K. Jha, MD, MPH, discusses how the World Health Organization and other public health agencies are handling the Zika virus, and what role the media plays in their responses to global pandemics.
Transcript (modified)
In the past you spoke out about how the World Health Organization handled the Ebola crisis. Now WHO has declared the Zika virus an international public health crisis. Has there been an improvement in how WHO handles these types of situations?
The Zika virus comes right on the heels of the catastrophe that was our response to Ebola. And Ebola really was a terrible lesson about how the world failed to respond effectively, and so the World Health Organization—lots of public health agencies—are under the microscope to get Zika right.
The good news is Zika is not as easily transmittable; it’s not quite as deadly as Ebola. But that all said, I do think WHO has acted more quickly, I do think other public health agencies are moving more quickly. The real question is: This urgency we see now, will it still be there when the media spotlight goes away in a few years?
The next big pandemic may not come when everybody is paying attention. And the question at that point will be: Will WHO and other public health agencies and countries respond quickly and effectively or do they need the media spotlight to do it?
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More